Clinical trial
Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA)…
NCT00213733 · University Hospital, Strasbourg, France, Other · Completed
Key facts
| NCT number | NCT00213733 |
|---|---|
| Title | Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer |
| Official title | Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer |
| Lead sponsor | University Hospital, Strasbourg, France, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Lung Cancer |
| Enrollment | 150 |
| Start date | Jun 1, 2004 |
| Completion | Aug 1, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 30, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: